A high-dose rehabilitation therapy improves motor outcomes in infants with perinatal stroke, offering rare evidence to guide ...

NEW ORLEANS, LA—Adding the factor XIa inhibitor asundexian (Bayer) to antiplatelet therapy tops antiplatelet therapy alone ...

For infants and toddlers who have had a stroke, a new treatment that restricted the use of their stronger arm and hand to encourage them to use their stroke-affected arm and hand, combined with ...

The factor XIa inhibitor asundexian reduced recurrent ischemic stroke without increasing major or minor bleeding in patients ...

Traditional stroke rehabilitation therapy focuses on restoring strength and movement to the more impaired side of the body, ...

The rationale behind the treatment is that, because genetic FXI deficiency has been linked with reduced risk of ischemic ...

Bayer presented the data from OCEANIC-STROKE at the International Stroke Conference 2026 in New Orleans.

A stroke blocks off blood supply to the brain - and the damage happens quickly.

The American Heart Association/American Stroke Association released its 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke. Stroke published the guideline on Monday.

A type of therapy that stimulates specific brain pathways with electromagnetic pulses combined with physical therapy ...

Study findings suggest the therapeutic window for DAPT benefit may extend up to 42 hours, but risk increases after 72 hours.

When someone is affected by a stroke, the standard treatment to restore blood flow to the brain can both save their life and cause additional damage – damage which a new, injectable nanomaterial ...